Erythema nodosum is an inflammatory skin condition characterized by the appearance of red, painful, and firm nodules, primarily located on the shins, but which can also spread to the thighs or arms. Also known as panniculitis, this condition, while perplexing, requires a thorough understanding of its symptoms and causes to be managed effectively. It often presents with general symptoms such as a low-grade fever, joint and muscle pain, and unusual fatigue. These signs frequently precede the appearance of hot and very painful nodules under the skin.

Possible causes include infections (bacterial, viral, or parasitic), autoimmune diseases such as sarcoidosis or Crohn's disease, as well as reactions to certain medications. An accurate diagnosis is essential to provide appropriate treatment.

Finally, in addition to treatments, personalized care helps minimize potential complications while improving the patient's daily comfort.

Understanding Erythema Nodosum

Definition and Characteristics

Erythema nodosum is an inflammatory skin condition characterized by the appearance of deep, painful subcutaneous nodules. It primarily affects the deeper layers of the skin, particularly the dermis and hypodermis. These nodules, often referred to as nodules, are inflammatory formations of adipose tissue that can grow to several centimeters in diameter. Red or purple in color, they are characterized by intense heat to the touch and significant pain. The characteristic symptoms of erythema nodosum vary, with general symptoms often preceding the skin manifestations. Before the nodules appear, patients may experience a low-grade fever, joint or muscle pain, as well as unusual fatigue, which can sometimes affect their quality of life. Subsequently, erythematous plaques or nodules appear, primarily affecting the front of the shins. However, they can also affect the thighs or arms, although this is less common. These nodules are palpable, very painful to the touch, and sometimes develop into bruises. Swelling of the ankles and inflammation of the knees may sometimes complete this clinical picture.

Risk Factors and Underlying Causes

Various factors can cause erythema nodosum. Common causes include various infections: bacterial infections (such as streptococcal pharyngitis or Salmonella enteritis), viral infections (notably hepatitis B and C or HIV), or certain parasitic infections, such as toxoplasmosis.

Medications are also potential triggers. For example, certain antibiotics, estrogens, and proton pump inhibitors such as omeprazole are among the medications suspected of playing a role in this condition. Finally, certain autoimmune diseases, such as sarcoidosis, lupus, or chronic inflammatory bowel diseases (such as ulcerative colitis or Crohn's disease), also represent significant risk factors. However, it is important to emphasize that in nearly 50% of cases, no underlying cause is identified, which can complicate management.

Diagnostic Procedure for Erythema Nodosum

Interview and Clinical Examination

The diagnosis of erythema nodosum begins with a thorough interview with the patient. This interview is essential for gathering information about the patient’s symptoms, such as the presence of nodules, fever, joint or muscle pain, fatigue, and other associated clinical signs. It also helps clarify the circumstances surrounding the onset of symptoms, current or recently taken medications, any underlying medical conditions, as well as the patient’s medical, family, and infectious disease history.

The clinical examination, which is equally important, must be performed meticulously. Among the specific points to note, palpation of the nodules is more crucial than visual inspection. These nodules, which are often indicative of the disease, should be well-defined, firm, tender to the touch, and generally measure between 1 and 5 cm in diameter. They are usually located on the anterior aspect of the shins, may be bilateral but asymmetrical, and appear surrounded by diffuse erythema. The clinical examination should also look for potentially associated systemic signs, such as joint swelling or reactive or satellite lymphadenopathy, which may suggest an autoimmune or infectious cause. Further Tests and Examinations: To confirm the diagnosis and identify possible underlying causes, various additional tests and examinations are often necessary. For example, a chest X-ray or CT scan can detect lymphadenopathy characteristic of conditions such as sarcoidosis. As for anti-streptolysin O (ASLO) antibody tests or throat cultures, they are useful for confirming a streptococcal infection. Skin tests specifically for tuberculosis or digestive investigations, such as a colonoscopy, may be recommended when inflammatory bowel disease (IBD) remains suspected. Furthermore, blood tests are essential to evaluate inflammatory markers (ESR, CRP), a complete blood count (CBC), as well as additional parameters such as transaminases, streptococcal serology, and antinuclear antibodies (ANA). In specific cases, a wedge biopsy is considered to formally confirm the diagnosis or demonstrate septal panniculitis associated with a nonspecific granulomatous reaction.

Differential diagnosis: distinguishing erythema nodosum from other skin conditions

Conducting a differential diagnosis is essential to rule out other skin conditions with similar symptoms. Among these, infectious cellulitis, thrombophlebitis, lupus, and other forms of panniculitis should be noted.

By carefully distinguishing erythema nodosum from these conditions, patients can be offered treatment tailored to their specific condition, thereby avoiding inappropriate care that could worsen their condition.

Therapeutic Strategies for Erythema Nodosum

Drug Treatments

Drug treatment for erythema nodosum is primarily focused on managing symptoms and addressing the underlying cause. For example, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen are commonly prescribed to reduce inflammation and relieve pain associated with the nodules. Potassium iodide may also be an option for reducing inflammation. Although less frequently used, it is prescribed at a dose of 300 to 500 mg orally, usually three times a day. This agent may be beneficial in certain specific cases, although its use is reserved for well-defined situations. In particularly severe forms of erythema nodosum or those that do not respond to conventional treatments, oral corticosteroids may be considered. However, this option is used with caution due to potential side effects, including the risk of worsening an undetected underlying infection.

Non-pharmacological approaches

Non-pharmacological treatments complement pharmacological options and play an important role in patient care. For example, bed rest and elevating the legs are often recommended to reduce both pain and inflammation.

Applying cold compresses to the nodules can also provide significant relief. In addition, supportive devices such as compression stockings and leg elevation can reduce swelling while improving overall patient comfort. These measures, although simple, are often effective in limiting the intensity of symptoms in most cases. Monitoring and Management of Possible Recurrences: Careful monitoring is essential to track the progression of erythema nodosum and prevent possible recurrences. Patients are advised to pay attention to any changes in their skin and report the appearance of new symptoms. In most cases, erythema nodosum resolves spontaneously within 3 to 6 weeks. However, recurrences can occur, especially if the underlying cause remains untreated. Constant communication between the patient and the doctor is essential to best adjust treatments and identify factors contributing to potential relapses. Finally, for healthcare professionals, continuing education and practical workshops, such as specialized dermatology CPD courses, offer valuable tools to refine their skills in diagnosing and managing these complex conditions. Preventing Erythema Nodosum and its Complications src="https://cdn.prod.website-files.com/61f1c5bbc327ec3679e7457c/67c5c6afaa7e0be467961076_96240561116.webp" width="auto" height="auto" loading="auto">

Identification and management of underlying causes

Prevention of erythema nodosum begins with a thorough identification and appropriate management of the underlying causes. It is essential to diagnose and effectively treat any infections—whether bacterial, viral, or fungal—that may be causing this condition.

For example, streptococcal infections—which are often implicated in triggering erythema nodosum—require treatment with specific antibiotics to prevent recurrence. Equally important, autoimmune diseases and chronic inflammatory bowel diseases (such as sarcoidosis, Crohn's disease, or ulcerative colitis) must be monitored and treated appropriately. Appropriate management of these underlying conditions helps significantly reduce the risk of developing erythema nodosum.

Tips for Reducing the Risk of Recurrence

To minimize the risk of recurrence, several recommendations are essential. In cases of drug sensitivity, it is strongly recommended to identify and avoid triggering substances, such as certain antibiotics, estrogens, or omeprazole. If their use is necessary, it must be done under strict medical supervision.

In addition, a balanced lifestyle plays a key role: a healthy diet, combined with regular physical activity and active stress management, can strengthen the immune system while reducing the risk of recurrence. To further enhance this prevention, it is recommended to protect oneself against common infections. For example, vaccination against influenza or streptococcal infections can be particularly beneficial in limiting triggering factors. The Importance of Regular Follow-Up: Regular medical follow-up is essential not only to prevent potential complications of erythema nodosum, but also to detect any recurrence early. Patients should be encouraged to carefully monitor their symptoms and report any suspicious changes, whether cutaneous or systemic. Additional tests, such as blood tests or X-rays, can be performed periodically to monitor the progression of the disease and adjust treatment, if necessary. This follow-up also provides an opportunity to address underlying conditions early, thereby reducing the risk of severe complications in the long term. Open and regular communication between doctor and patient is essential for optimal management of this condition. Conclusion: Erythema nodosum is an inflammatory skin disease primarily characterized by the appearance of painful nodules, often located on the shins. To fully understand this condition, it is essential to understand its origins, symptoms, and appropriate treatment options. Underlying causes, such as infections, drug reactions, or autoimmune diseases, must be identified and managed rigorously. Diagnosis relies on a careful clinical examination, often supplemented by specific tests to precisely determine the underlying cause. As for treatments, they aim to reduce pain and inflammation through the use of nonsteroidal anti-inflammatory drugs (NSAIDs), rest, and, if necessary, the administration of corticosteroids. Regular follow-up is essential, not only to prevent recurrences but also to manage any associated underlying conditions. Understanding these different aspects will allow you to act quickly in case of symptoms, by consulting a healthcare professional for effective treatment and optimal management of this condition. FAQ What are the most common causes of erythema nodosum? Erythema nodosum is most often caused by various diseases or triggering factors. Examples include streptococcal infections, such as tonsillitis or upper respiratory infections, as well as sarcoidosis. Bacteria like Yersinia and viruses such as the Epstein-Barr virus are also among the causative agents. Furthermore, certain chronic inflammatory bowel diseases, particularly Crohn’s disease or ulcerative colitis, as well as the use of specific medications, can be implicated. How do the symptoms of erythema nodosum manifest? Symptoms typically begin with a low-grade fever (around 38°C to 39°C), accompanied by joint and muscle pain, and marked fatigue. After 3 to 4 days, painful and inflamed nodules appear, mainly on the front of the shins and legs, but sometimes also on the thighs or arms. These nodules are characterized by their red appearance and warmth to the touch. They may be accompanied by swelling in the ankles. Over time, these nodules change color, evolving from bright red to blue-violet, then to yellow-green before disappearing completely.

What are the main treatments for relieving the symptoms of erythema nodosum?

The management of erythema nodosum is based on several approaches:

• Treatment of the underlying cause: When a specific cause is identified, such as a streptococcal infection or sarcoidosis, appropriate treatment—for example, antibiotic or corticosteroid therapy—must be initiated.
• Rest and supportive care: Bed rest, elevating the legs, applying cold compresses, and wearing compression stockings can help reduce pain and inflammation.
• Anti-inflammatory medications: Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, or indomethacin may be prescribed. In some cases, potassium iodide can also help reduce inflammation.
• Pain relievers: Paracetamol or aspirin can be used to manage pain associated with the nodules.

How is erythema nodosum diagnosed, and what tests might be necessary?

Diagnosis is primarily based on a thorough clinical examination, including palpation of the nodules and a detailed medical history to identify symptoms and their potential triggers. Several additional tests may be performed, depending on the patient's medical history and the doctor's suspicions. These tests include a complete blood count, a C-reactive protein (CRP) test, stool analysis, throat swabs, and even a chest X-ray. In some complex cases, an upper endoscopy may be considered. Finally, a skin biopsy may be useful to confirm the presence of septal panniculitis and rule out other potential causes.